{
    "name": "luspatercept",
    "comment": "Rx",
    "other_names": [
        "Reblozyl",
        "luspatercept-aamt"
    ],
    "classes": [
        "Erythroid Maturation Agents"
    ],
    "source": "https://reference.medscape.com/drug/reblozyl-luspatercept-1000359",
    "pregnancy": {
        "common": [
            "There are no available data on drug use in pregnant women to inform a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes",
            "Pregnancy testing recommended for females of reproductive potential before starting treatment"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Based on findings in animal reproduction studies, therapy may cause fetal harm when administered to a pregnant woman; in animal reproduction studies, administration to pregnant rats and rabbits during the period of organogenesis resulted in adverse developmental outcomes, including embryofetal mortality, alterations to growth, and structural abnormalities at exposures 13 times (rats) and 18 times (rabbits) of maximum recommended human dose (MRHD); advise pregnant women of potential risk to a fetus"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential: Use effective contraception during treatment and for at least 3 months after last dose; may cause embryofetal harm when administered to pregnant women"
                ]
            },
            {
                "type": "Infertility",
                "description": [
                    "Females: Based on findings in animals, therapy may impair female fertility; adverse effects on fertility in female rats were reversible after a 14-week recovery period"
                ]
            }
        ]
    },
    "lactation": null,
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Increased risk of thrombosis/thromboembolism in patients with beta thalassemia; patients with known risk factors for thromboembolism, eg, splenectomy or concomitant use of hormone replacement therapy, may be at further increased risk; consider thromboprophylaxis in patients with beta thalassemia at increased risk;.monitor for signs and symptoms of and institute treatment promptly",
                "Monitor for hypertension; monitor blood pressure prior to each administration; manage new-onset hypertension or exacerbations of preexisting hypertension using anti-hypertensive agents",
                "May cause fetal harm; advise females of reproductive potential of potential risk to fetus and use of effective contraception"
            ],
            "specific": [
                {
                    "type": "Extramedullary hematopoietic masses (EMH)",
                    "description": [
                        "EMH observed in treated patients with transfusion-dependent beta-thalassemia",
                        "Incidence of EMH was higher in non-transfusion dependent beta-thalassemia compared to placebo",
                        "Spinal cord compression symptoms due to EMH masses reported",
                        "Possible risk factors for developing EMH include history of EMH masses, splenectomy, splenomegaly, hepatomegaly, or low baseline hemoglobin (<8.5 g/dL)",
                        "Monitor at initiation and during treatment for symptoms and signs or complications resulting from EMH masses and treat accordingly",
                        "Discontinue treatment in case of serious complications due to EMH masses",
                        "Avoid use in patients requiring treatment to control the growth of EMH masses"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Total bilirubin",
            "percent": "2"
        },
        {
            "name": "x ULN",
            "percent": "64"
        },
        {
            "name": "Headache",
            "percent": "26"
        },
        {
            "name": "Musculoskeletal",
            "percent": "20"
        },
        {
            "name": "Bone pain",
            "percent": "19"
        },
        {
            "name": "Arthralgia",
            "percent": "14"
        },
        {
            "name": "Fatigue",
            "percent": "14"
        },
        {
            "name": "Abdominal pain",
            "percent": "14"
        },
        {
            "name": "Cough",
            "percent": "12"
        },
        {
            "name": "Diarrhea",
            "percent": "3"
        },
        {
            "name": "ALT or AST",
            "percent": "11-12"
        },
        {
            "name": "x ULN",
            "percent": "11"
        },
        {
            "name": "Dizziness",
            "percent": "41"
        },
        {
            "name": "Fatigue",
            "percent": "27"
        },
        {
            "name": "Reduced creatinine clearance",
            "percent": "20"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "18"
        },
        {
            "name": "Dizziness",
            "percent": "16"
        },
        {
            "name": "vertigo",
            "percent": "16"
        },
        {
            "name": "Nausea",
            "percent": "14"
        },
        {
            "name": "Diarrhea",
            "percent": "13"
        },
        {
            "name": "Headache",
            "percent": "12"
        },
        {
            "name": "Dyspnea",
            "percent": "9"
        },
        {
            "name": "Total bilirubin elevated",
            "percent": "8"
        },
        {
            "name": "Nausea",
            "percent": "2"
        },
        {
            "name": "Hypertension",
            "percent": "8"
        },
        {
            "name": "Alkaline phosphatase",
            "percent": "7"
        },
        {
            "name": "ALP",
            "percent": "2"
        },
        {
            "name": "x ULN",
            "percent": "6"
        },
        {
            "name": "Hyperuricemia",
            "percent": "3"
        },
        {
            "name": "Direct bilirubin",
            "percent": "2"
        },
        {
            "name": "x ULN",
            "percent": "10"
        },
        {
            "name": "Extramedullary hematopoietic masses",
            "percent": "9"
        },
        {
            "name": "and spinal cord compression",
            "percent": "8"
        },
        {
            "name": "Hyperuricemia",
            "percent": "8"
        },
        {
            "name": "Hypertension",
            "percent": "7"
        },
        {
            "name": "Hypersensitivity reactions",
            "percent": "7"
        },
        {
            "name": "ALT elevated",
            "percent": "6"
        },
        {
            "name": "Renal impairment",
            "percent": "4"
        },
        {
            "name": "Tachycardia",
            "percent": "7"
        },
        {
            "name": "Injection site reactions",
            "percent": "2"
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": "1"
        },
        {
            "name": "Influenza",
            "percent": null
        },
        {
            "name": "influenza like illness",
            "percent": null
        },
        {
            "name": "AST elevated",
            "percent": null
        },
        {
            "name": "Fatigue",
            "percent": null
        },
        {
            "name": "Renal impairment",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": null
        },
        {
            "name": "Hypersensitivity reactions",
            "percent": null
        }
    ]
}